XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022   124,336      
Beginning balance at Dec. 31, 2022 $ 955,158 $ 2 $ 1,666,106 $ (9,286) $ (701,664)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of vested stock options (in shares)   265      
Exercise of vested stock options 2,008   2,008    
Vesting of restricted stock units (in shares)   4,191      
Issuance of restricted stock units related to bonus (in shares)   1,193      
Issuance of restricted stock units related to bonus program $ 16,599   16,599    
Shares issued under ESPP (in shares) 700 697      
Shares issued under ESPP $ 4,977   4,977    
Stock-based compensation 92,180   92,180    
Net loss (109,702)       (109,702)
Other comprehensive income 7,352     7,352  
Ending balance (in shares) at Sep. 30, 2023   130,682      
Ending balance at Sep. 30, 2023 968,572 $ 2 1,781,870 (1,934) (811,366)
Beginning balance (in shares) at Jun. 30, 2023   129,027      
Beginning balance at Jun. 30, 2023 987,754 $ 2 1,747,959 (3,152) (757,055)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of vested stock options (in shares)   144      
Exercise of vested stock options $ 1,137   1,137    
Vesting of restricted stock units (in shares)   1,511      
Shares issued under ESPP (in shares) 0        
Stock-based compensation $ 32,774   32,774    
Net loss (54,311)       (54,311)
Other comprehensive income 1,218     1,218  
Ending balance (in shares) at Sep. 30, 2023   130,682      
Ending balance at Sep. 30, 2023 $ 968,572 $ 2 1,781,870 (1,934) (811,366)
Beginning balance (in shares) at Dec. 31, 2023 133,000 132,992      
Beginning balance at Dec. 31, 2023 $ 979,488 $ 3 1,815,245 (1,008) (834,752)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of vested stock options (in shares) 125 125      
Exercise of vested stock options $ 310   310    
Vesting of restricted stock units (in shares)   4,530      
Issuance of restricted stock units related to bonus (in shares)   1,889      
Issuance of restricted stock units related to bonus program $ 26,849   26,849    
Shares issued under ESPP (in shares) 500 544      
Shares issued under ESPP $ 4,053   4,053    
Stock-based compensation 82,940   82,940    
Net loss (125,172)       (125,172)
Other comprehensive income $ 986     986  
Ending balance (in shares) at Sep. 30, 2024 140,100 140,080      
Ending balance at Sep. 30, 2024 $ 969,454 $ 3 1,929,397 (22) (959,924)
Beginning balance (in shares) at Jun. 30, 2024   138,396      
Beginning balance at Jun. 30, 2024 981,187 $ 3 1,903,374 (282) (921,908)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of vested stock options (in shares)   7      
Exercise of vested stock options $ 19   19    
Vesting of restricted stock units (in shares)   1,677      
Shares issued under ESPP (in shares) 0        
Stock-based compensation $ 26,004   26,004    
Net loss (38,016)       (38,016)
Other comprehensive income $ 260     260  
Ending balance (in shares) at Sep. 30, 2024 140,100 140,080      
Ending balance at Sep. 30, 2024 $ 969,454 $ 3 $ 1,929,397 $ (22) $ (959,924)